Oncorus Inc. Gains 28.1%

Mon, Oct 23, 2023 at 07:16 PM

Oncorus Inc. (ONCR:NASDAQ) shot up at $0.03, a gain of 28.1%. From Mon, Oct 09, 2023, the stock recorded 0.00% Up Days and 0.00% Green Days

About Oncorus Inc. (ONCR:NASDAQ)

Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients.

Top 10 Gainers:

Unico American Corporation (UNAM:NASDAQ), 455%
LumiraDx Limited (LMDX:NASDAQ), 215.98%
Akumin Inc. (AKU:NASDAQ), 144.86%
Textainer Group Holdings Limited (TGH:NYSE), 44.69%
CEL-SCI Corporation (CVM:NYSEMKT), 41.12%
Kiromic BioPharma Inc. (KRBP:NASDAQ), 35.96%
Oncorus Inc. (ONCR:NASDAQ), 28.1%
Leju Holdings Limited (LEJU:NYSE), 27.93%
Mitcham Industries, Inc. (MIND:NASDAQ), 26.92%
Vinco Ventures Inc. (BBIG:NASDAQ), 25%